Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 510810, 9 pages
http://dx.doi.org/10.1155/2015/510810
Research Article

Carbohydrate Microarrays Identify Blood Group Precursor Cryptic Epitopes as Potential Immunological Targets of Breast Cancer

1Tumor Glycomics Laboratory, SRI International Biosciences Division, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA
2Department of Pharmacology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA
3Department of Pathology, David Geffen School of Medicine, University of California in Los Angeles, 570 Westwood Plaza, Los Angeles, CA 90095, USA

Received 25 April 2015; Revised 1 August 2015; Accepted 6 August 2015

Academic Editor: Paola Nistico

Copyright © 2015 Denong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Hakomori, “Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens,” Advances in Cancer Research, vol. 52, pp. 257–331, 1989. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Fukuda, “Possible roles of tumor-associated carbohydrate antigens,” Cancer Research, vol. 56, no. 10, pp. 2237–2244, 1996. View at Google Scholar · View at Scopus
  3. D. H. Dube and C. R. Bertozzi, “Glycans in cancer and inflammation—potential for therapeutics and diagnostics,” Nature Reviews Drug Discovery, vol. 4, no. 6, pp. 477–488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. F. Codington, B. H. Sanford, and R. W. Jeanloz, “Glycoprotein coat of the TA3 cell. Isolation and partial characterization of a sialic acid containing glycoprotein fraction,” Biochemistry, vol. 11, no. 14, pp. 2559–2564, 1972. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Li, J. L. Yao, P. A. Bourne, P. A. Di Sant'Agnese, and J. Huang, “Frequent expression of human carcinoma-associated antigen, a mucin-type glycoprotein, in cells of prostatic carcinoma,” Archives of Pathology & Laboratory Medicine, vol. 128, no. 12, pp. 1412–1417, 2004. View at Google Scholar · View at Scopus
  6. K. I. Al-Shibli, H. A. Mohammed, and K. S. Mikalsen, “Sentinel lymph nodes and breast carcinoma: analysis of 70 cases by frozen section,” Annals of Saudi Medicine, vol. 25, no. 2, pp. 111–114, 2005. View at Google Scholar · View at Scopus
  7. J. Akimoto, H. Namatame, J. Haraoka, and M. Kudo, “Epithelioid glioblastoma: a case report,” Brain Tumor Pathology, vol. 22, no. 1, pp. 21–27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Liang, J. Yao, P. A. Bourne, P. A. DiSant'Agnese, J. Huang, and J.-Y. Lei, “Overexpression of human carcinoma-associated antigen in esophageal adenocarcinoma and its precursor lesions,” American Journal of Clinical Pathology, vol. 122, no. 5, pp. 747–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Thingstad, S. Haavik, K. Hansen, K. Sletten, J. F. Codington, and H. Barsett, “Human carcinoma-associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma; comparison with epiglycanin,” European Journal of Pharmaceutical Sciences, vol. 6, no. 2, pp. 121–129, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. Yao, P. A. Bourne, Q. Yang, J. Lei, P. A. Di Sant'Agnese, and J. Huang, “Overexpression of human carcinoma-associated antigen in urothelial carcinoma of the bladder,” Archives of Pathology and Laboratory Medicine, vol. 128, no. 7, pp. 785–787, 2004. View at Google Scholar · View at Scopus
  11. S. Haavik, M. Nilsen, T. Thingstad et al., “Specificity studies of an antibody developed against a mucin-type glycoprotein,” Glycoconjugate Journal, vol. 16, no. 3, pp. 229–236, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. J. F. Codington, S. Haavik, N. Nikrui et al., “Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples,” Cancer, vol. 94, no. 3, pp. 803–813, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Clausen, M. Stroud, J. Parker, G. Springer, and H. Sen-Itiroh, “Monoclonal antibodies directed to the blood group a associated structure, galactosyl-A: specificity and relation to the thomsen-friedenreich antigen,” Molecular Immunology, vol. 25, no. 2, pp. 199–204, 1988. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Palma, Y. Liu, R. A. Childs et al., “The human epithelial carcinoma antigen recognized by monoclonal antibody AE3 is expressed on a sulfoglycolipid in addition to neoplastic mucins,” Biochemical and Biophysical Research Communications, vol. 408, no. 4, pp. 548–552, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Wang, S. Liu, B. J. Trummer, C. Deng, and A. Wang, “Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells,” Nature Biotechnology, vol. 20, no. 3, pp. 275–281, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. N. Wang, H. T. Chen, J. Liao et al., “Two families of monoclonal antibodies to alpha(1–6)dextran, VH19.1.2 and VH9.14.7, show distinct patterns of J kappa and JH minigene usage and amino acid substitutions in CDR3,” The Journal of Immunology, vol. 145, pp. 3002–3010, 1990. View at Google Scholar
  17. D. Wang, L. Dafik, R. Nolley et al., “Anti-oligomannose antibodies as potential serum biomarkers of aggressive prostate cancer,” Drug Development Research, vol. 74, no. 2, pp. 65–80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Kabat, Blood Group Substances, Their Chemistry and Immunochemistry, Academic Press, New York, NY, USA, 1956.
  19. G. Vicari and E. A. Kabat, “Immunochemical studies on blood groups. XLV. Structures and activities of oligosaccharides produced by alkaline degradation of a blood group substance lacking A,B,H,Lea, and Leb specificities,” Biochemistry, vol. 9, no. 17, pp. 3414–3421, 1970. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Feizi, E. A. Kabat, G. Vicari, B. Anderson, and W. L. Marsh, “Immunochemical studies on blood groups. XLIX. The I antigen complex: specificity differences among anti-I sera revealed by quantitative precipitin studies; partial structure of the I determinant specific for one anti-I serum,” Journal of Immunology, vol. 106, no. 6, pp. 1578–1592, 1971. View at Google Scholar · View at Scopus
  21. T. Feizi, E. A. Kabat, G. Vicari, B. Anderson, and W. L. Marsh, “Immunochemical studies on blood groups. XLVII. The I antigen complex—precursors in the A, B, H, Lea, and leb blood group system—hemagglutination-inhibition studies,” Journal of Experimental Medicine, vol. 133, no. 1, pp. 39–52, 1971. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Wu, K.-H. Khoo, S.-Y. Yu, Z. Yang, R. Kannagi, and W. M. Watkins, “Glycomic mapping of pseudomucinous human ovarian cyst glycoproteins: identification of Lewis and sialyl Lewis glycotopes,” Proteomics, vol. 7, no. 20, pp. 3699–3717, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Codington, N. Mass, S. Haavik, and D. Norway, “Antibodies to human carcinoma antigen,” US Patent no. 5,693,763, 1997.
  24. C. Gao, Y. Liu, H. Zhang et al., “Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array,” The Journal of Biological Chemistry, vol. 289, no. 23, pp. 16462–16477, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Nonaka, M. N. Fukuda, C. Gao et al., “Determination of carbohydrate structure recognized by prostate-specific F77 monoclonal antibody through expression analysis of glycosyltransferase genes,” The Journal of Biological Chemistry, vol. 289, no. 23, pp. 16478–16486, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Maisonrouge-McAuliffe and E. A. Kabat, “Immunochemical studies on blood groups. Fractionation, heterogeneity, and chemical and immunochemical properties of a blood group substance with B, I, and I activities purified from human ovarian cyst fluid,” Archives of Biochemistry and Biophysics, vol. 175, no. 1, pp. 71–80, 1976. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Z. Allen and E. A. Kabat, “Immunochemical studies on blood groups. XXII. Immunochemical studies on the nondialyzable residue from partially hydrolyzed blood group A, B and O(H) substances (P1 fractions),” Journal of immunology, vol. 82, no. 4, pp. 340–357, 1959. View at Google Scholar · View at Scopus
  28. S. K. Sikder, E. A. Kabat, D. D. Roberts, and I. J. Goldstein, “Immunochemical studies on the combining site of the blood group A-special lima bean lectin,” Carbohydrate Research, vol. 151, pp. 247–260, 1986. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Brockhausen, “Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions,” EMBO Reports, vol. 7, no. 6, pp. 599–604, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Maisonrouge-McAuliffe and E. A. Kabat, “Immunochemical studies on blood groups. Structures and immunochemical properties of oligosaccharides from two fractions of blood group substance from human ovarian cyst fluid differing in B, I, and i activities and reactivity toward concanavalin A,” Archives of Biochemistry and Biophysics, vol. 175, no. 1, pp. 90–113, 1976. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Maisonrouge-McAuliffe and E. A. Kabat, “Immunochemical studies on blood groups. Heterogeneity of oligosaccharides liberated by degradation with alkaline borohydride of two human ovarian cyst fractions differing in B, I, and i activities and in reactivity toward concanavalin A,” Archives of Biochemistry and Biophysics, vol. 175, no. 1, pp. 81–89, 1976. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Tadano and I. Ishizuka, “Isolation and characterization of the sulfated gangliotriaosylceramide from rat kidney,” The Journal of Biological Chemistry, vol. 257, no. 3, pp. 1482–1490, 1982. View at Google Scholar · View at Scopus
  33. T. B. H. Geijtenbeek, R. Torensma, S. J. van Vliet et al., “Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses,” Cell, vol. 100, no. 5, pp. 575–585, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Feinberg, D. A. Mitchell, K. Drickamer, and W. I. Weis, “Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR,” Science, vol. 294, no. 5549, pp. 2163–2166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. A. S. Powlesland, E. M. Ward, S. K. Sadhu, Y. Guo, M. E. Taylor, and K. Drickamer, “Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins,” The Journal of Biological Chemistry, vol. 281, no. 29, pp. 20440–20449, 2006. View at Publisher · View at Google Scholar · View at Scopus